4.5 Article

Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00206.2003

Keywords

15-deoxy-Delta(12,14)-prostaglandin J(2); rosiglitazone; peroxisome proliferator-activated receptor-gamma 2

Funding

  1. NHLBI NIH HHS [HL-57243, P50 HL-60289, HL-58200, K08 HL-070068] Funding Source: Medline

Ask authors/readers for more resources

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a member of the nuclear hormone receptor family of ligand-dependent transcription factors, is a critical regulator of adipocyte differentiation and glucose metabolism. The expression, regulation, and functional significance of PPAR-gamma in alveolar macrophages (AMs), the predominant resident immune effector cell within the alveolus, have not been previously examined. In this study, we show that, in contrast to peritoneal macrophages, resident murine AMs constitutively express high levels of PPAR-gamma. Expression was primarily located in the nucleus by immunofluorescence staining. Quantitative real-time RT-PCR demonstrated that the predominant isoform was PPAR-gamma2. Expression of PPAR-gamma was induced by the anti-inflammatory cytokine IL-4. Treatment of murine AMs with PPAR-gamma ligands suppresses PMA-stimulated oxidative burst activity and LPS + IFN-gamma-mediated expression of inducible nitric oxide synthase. In addition, LPS-induced IL-12 mRNA and protein expression was inhibited by PPAR-gamma ligands. These results support an important immunomodulatory role for PPAR-gamma in AM responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available